AbbVie CEO Richard Gonzalez to step down on July 1, 2023, succeeded by president and COO Robert Michael; Gonzalez becomes executive chair.
AbbVie CEO Richard Gonzalez to step down on July 1, 2023, and be replaced by company's current president and COO, Robert Michael. Gonzalez will become executive chair of the board of directors. The change in leadership comes as AbbVie faces competition for its blockbuster autoimmune drug Humira and is closing major acquisitions. Gonzalez has been credited with navigating Humira's loss of exclusivity, and Michael has played a key role in business development.
February 20, 2024
12 Articles